A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: A Gynecologic Oncology Group Study

Gynecologic Oncology

Volumn 62, Issue 2, 1996, Pages 278-281

  Ball, Harrison G ^a   Blessing, John A ^b   Lentz, Samuel S ^c   Mutch, David G ^d  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; CIMETIDINE; DEXAMETHASONE; DIPHENHYDRAMINE; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; CANCER RADIOTHERAPY; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ENDOMETRIUM CARCINOMA; FEMALE; GASTROINTESTINAL SYMPTOM; GRANULOCYTE; HUMAN; HYSTERECTOMY; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; NEUROTOXICITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENT CANCER; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE COUNT;

EID: 0030220145     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0227     Document Type: Article

References (8)

1. 1. Wingo, P. A., Tong, T., and Bolden, S. Cancer statistics, 1995, C Cancer J. Clin. 45, 18-30 (1995).
2. 2. Thigpen, J. T., Blessing, J. A., Homesley, H., Creasman, W. T., and Sutton, G. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study, Gynecol. Oncol. 33, 68-70 (1989).
3. 3. Thigpen, T., Buchsbaum, H., Mangan, C., and Blessing, J. P. Phase II trial of adriamycin in the treatment of advanced or recurrent endometrial carcinoma, Cancer Treat. Rep. 63, 21-27 (1979).
4. 4. Thigpen, J. T., Blessing, J. A., Ball, H., Hummel, S. J., and Barrett, R. J. Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: A Gynecologic Oncology Group study, J. Clin. Oncol. 12, 1748-1753 (1994).
5. 5. Moore, T. D., Phillips, P. H., Nerenstone, S. R., and Cheson, B. D. Systemic treatment of advanced and recurrent endometrial carcinoma: Current status and future directions, J. Clin. Oncol. 9, 1071-1088 (1991).
6. 6. Muss, H. B. Chemotherapy of metastatic endometrial cancer, Semin. Oncol. 21, 107-113 (1994).
7. 7. Barrett, R. J., Blessing, J. A., Homesley, H. D., Twiggs, L., and Webster, K. D. Circadian-timed combination doxorubicin-cisplatin chemotherapy for advanced endometrial carcinoma: A phase II study of the Gynecologic Oncology Group, Am. J. Clin. Oncol. 16, 494-496 (1993).
8. 8. Rowinsky, E. K., and Donehower, R. C. Paclitaxel (Taxol), N. Engl. J. Med. 332, 1004-1014 (1995).